Disease/Infection News

RSS

Researchers develop new malaria vaccine strategy based on ingestion of genetically modified starch

Researchers from two laboratories in northern France have successfully vaccinated and protected mice by feeding them starch derived from green algae and genetically modified to carry vaccine proteins.

21 Dec 2010

Training more effective than anti-inflammatory drugs in treating tennis elbow

Training and ergonomic advice are more effective than anti-inflammatory drugs and cortisone injections in treating tennis elbow, and give fewer side effects. This is the conclusion of a thesis presented at the University of Gothenburg, Sweden.

21 Dec 2010

Cholera deaths in Haiti top 2,500, health ministry says

The Haitian health ministry on Sunday said there had been 2,535 cholera deaths since the outbreak hit in mid-October, "dashing hopes the fatality rate might be beginning to taper off," Agence France-Presse reports.

21 Dec 2010

New research sheds light on complex regulatory pathways for effective innate immune system

New research by scientists at the University of California, San Diego School of Medicine and Skaggs School of Pharmacy and Pharmaceutical Sciences reveals that the immune system has an effective backup plan to protect the body from infection when the "master regulator" of the body's innate immune system fails.

21 Dec 2010

New CPT code for use with T-SPOT.TB test

Oxford Immunotec, Inc. announces that a new and specific Current Procedural Terminology (CPT®) code has been established by the American Medical Association for use with the T-SPOT®.TB test. The new Category I code, 86481, is described as "Tuberculosis test, cell mediated immunity antigen response measurement; enumeration of gamma interferon-producing T-cells in cell suspension." This new code will be effective as of January 1, 2011.

21 Dec 2010

Clue to the blues that come with the flu

Vanderbilt University researchers may have found a clue to the blues that can come with the flu - depression may be triggered by the same mechanisms that enable the immune system to respond to infection.

21 Dec 2010

Researchers show how malaria parasites infect red blood cells, impede blood flow to organs

Although the incidence of malaria has declined in all but a few countries worldwide, according to a World Health Organization report earlier this month, malaria remains a global threat. Nearly 800,000 people succumbed to the mosquito-borne disease in 2009, nearly all of them in the developing world.

21 Dec 2010

Hemispherx to manufacture and supply Alferon N Injection to GP Pharm in Argentina

Hemispherx Biopharma, Inc. announced that the Company has entered into an agreement with GP Pharm Latinoamerica, an affiliate company of Spanish GP Pharm SA for the marketing of Alferon N Injection®, the Company's natural interferon injection product which has been FDA approved for a category of sexually transmitted diseases in Argentina with an option for other Latin American countries upon receipt of those respective countries' regulatory approval for any use of the product.

21 Dec 2010

Bristol-Myers Squibb, Oncolys complete license agreement for festinavir

Bristol-Myers Squibb Company and Oncolys BioPharma Inc., a privately held biotechnology company based in Japan, announced today that the companies have signed a definitive agreement under which Bristol-Myers Squibb will acquire exclusive worldwide rights to manufacture, develop and commercialize festinavir, a once-a-day, orally available nucleoside reverse transcriptase inhibitor (NRTI) in Phase II development for HIV.

20 Dec 2010

Idera reports positive data from IMO-2125/ribavirin combination Phase 1 trial in null-responder HCV patients

Idera Pharmaceuticals, Inc. announced today preliminary data from a 4-week dose-ranging Phase 1 clinical trial of IMO-2125 in combination with ribavirin in 60 treatment-naïve patients with genotype 1 chronic hepatitis C virus (HCV) infection. In the trial, treatment with IMO-2125 in combination with ribavirin was well tolerated and achieved substantial decline in virus levels at two days after the first dose of IMO-2125 and after four weeks of treatment.

20 Dec 2010

AHF calls on Sen. Nelson to address Florida's AIDS drug crisis

On Monday, December 20 at 6:00 PM, AIDS Healthcare Foundation (AHF) will host a town hall and public forum at the African Heritage Cultural Arts Center calling on U.S. Senator Bill Nelson to immediately address Florida's AIDS drug crisis which has left nearly 2,400 patients without access to lifesaving AIDS medications. Town hall attendees will include AIDS advocates, patients, healthcare professionals, community leaders and concerned citizens.

20 Dec 2010

New communication toolkit could improve information and advice on emerging food risks

Improvements in the delivery of information and advice on emerging food risks could lead to fewer food-related illnesses, a reduction in economic losses related to food scares, and improved consumer confidence in foods.

20 Dec 2010

FDA warns against consumption of Sally Jackson cheese due to risk of E. coli O157:H7

The FDA, in cooperation with other state and local public health agencies, is warning consumers not to eat any Sally Jackson cheeses. The products were processed under conditions that create a significant risk of contamination of the unpasteurized raw milk and finished cheese, and Sally Jackson cheeses have been identified as one possible source of eight cases of E. coli O157 infections in an ongoing investigation.

20 Dec 2010

MDI adds McKesson's CareEnhance Disease Monitor software to Viewpoint Analytics solutions portfolio

MDI announced today that it has added McKesson's CareEnhance® Disease Monitor software to the Viewpoint Analytics solutions portfolio. Integrating one of the industry's leading disease management products increases the breadth of solutions available from Viewpoint Analytics.

20 Dec 2010

Walgreens partners with HHS to provide over $10M worth of flu shots for people without adequate health insurance

Walgreens and the U.S. Department of Health and Human Services (HHS) are teaming up in an effort to make 2011 a healthier New Year for those without adequate health insurance.

20 Dec 2010

Germany has not yet achieved influenza vaccination rates set by WHO

The World Health Organization set a target for the influenza vaccination rate for 2006 of more than 50% of the elderly population and an increase to more than 75% by 2010. These rates have thus far not been achieved in the old German states. In the current issue of Deutsches Ärzteblatt International (Dtsch Arztebl Int 2010; 107[48]: 845-50) the working group around Annicka M. Reuss presents rates from flu seasons past.

17 Dec 2010

Possible stem cell cure for AIDS

An explosion of stem cell breakthroughs, including a possible cure for AIDS, is reshaping the possibilities for curing deadly and debilitating diseases around the globe, says Emerging Healthcare Solutions President and CEO Cindy Morrissey.

17 Dec 2010

NIAID renews funding of PRIME to develop mathematical models to study influenza infection

Mount Sinai School of Medicine today announced that the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, has renewed funding of the Program for Research on Immune Modeling and Experimentation. This program seeks to develop easy-to-use, predictive mathematical models to better understand patterns of infection among individuals affected by the H1N1 and 1918 influenza viruses and other related viruses.

17 Dec 2010

U.N. says it will investigate source of Haitian cholera epidemic as death toll rises

The U.N. is looking into establishing an independent commission to identify the source of Haiti's cholera epidemic, Alain Le Roy, the U.N. under-secretary-general for peacekeeping operations, said on Wednesday, the Associated Press/Washington Post reports. "We are urging and we are calling for what we could call an international panel," Le Roy said at a news conference at the U.N. headquarters in New York. "We are in discussions with (the U.N. World Health Organization) to find the best experts to be in a panel to be completely independent," he added.

17 Dec 2010

Prions responsible for BSE can survive in new host environment

Scientists from the Florida campus of The Scripps Research Institute have shown that prions, bits of infectious protein that can cause fatal neurodegenerative disease such as bovine spongiform encephalopathy or "mad cow disease," have the ability to adapt to survive in a new host environment.

17 Dec 2010

Disease/Infection News

Researchers develop new malaria vaccine strategy based on ingestion of genetically modified starch

Training more effective than anti-inflammatory drugs in treating tennis elbow

Cholera deaths in Haiti top 2,500, health ministry says

New research sheds light on complex regulatory pathways for effective innate immune system

New CPT code for use with T-SPOT.TB test

Clue to the blues that come with the flu

Researchers show how malaria parasites infect red blood cells, impede blood flow to organs

Hemispherx to manufacture and supply Alferon N Injection to GP Pharm in Argentina

Bristol-Myers Squibb, Oncolys complete license agreement for festinavir

Idera reports positive data from IMO-2125/ribavirin combination Phase 1 trial in null-responder HCV patients

AHF calls on Sen. Nelson to address Florida's AIDS drug crisis

New communication toolkit could improve information and advice on emerging food risks

FDA warns against consumption of Sally Jackson cheese due to risk of E. coli O157:H7

MDI adds McKesson's CareEnhance Disease Monitor software to Viewpoint Analytics solutions portfolio

Walgreens partners with HHS to provide over $10M worth of flu shots for people without adequate health insurance

Germany has not yet achieved influenza vaccination rates set by WHO

Possible stem cell cure for AIDS

NIAID renews funding of PRIME to develop mathematical models to study influenza infection

U.N. says it will investigate source of Haitian cholera epidemic as death toll rises

Prions responsible for BSE can survive in new host environment

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Bioprocess Efficiency with Cell Density Monitoring

Exploring electron microscopy for plant and microbial imaging at the John Innes Centre

Latest News